Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults

Siti Madiani Abdul Ghani, Goon Jo Aan, Nor Helwa Ezzah Nor Azman, Siti Nor Asyikin Zakaria, Zalina Hamid, Wan Zurinah Wan Ngah

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: This study aims to compare the differential gene expression resulting from tocotrienol-rich fraction and α-tocopherol supplementation in healthy older adults. METHODS: A total of 71 eligible subjects aged 50 to 55 years from Gombak and Kuala Lumpur, Malaysia, were divided into three groups and supplemented with placebo (n=23), α-tocopherol (n=24) or tocotrienol-rich fraction (n=24). Blood samples were collected at baseline and at 3 and 6 months of supplementation for microarray analysis. RESULTS: The number of genes altered by α-tocopherol was higher after 6 months (1,410) than after 3 months (273) of supplementation. α-Tocopherol altered the expression of more genes in males (952) than in females (731). Similarly, tocotrienol-rich fraction modulated the expression of more genes after 6 months (1,084) than after 3 months (596) and affected more genes in males (899) than in females (781). α-Tocopherol supplementation modulated pathways involving the response to stress and stimuli, the immune response, the response to hypoxia and bacteria, the metabolism of toxins and xenobiotics, mitosis, and synaptic transmission as well as activated the mitogen-activated protein kinase and complement pathways after 6 months. However, tocotrienol-rich fraction supplementation affected pathways such as the signal transduction, apoptosis, nuclear factor kappa B kinase, cascade extracellular signal-regulated kinase-1 and extracellular signal-regulated kinase-2, immune response, response to drug, cell adhesion, multicellular organismal development and G protein signaling pathways. CONCLUSION: Supplementation with either α-tocopherol or tocotrienol-rich fraction affected the immune and drug response and the cell adhesion and signal transduction pathways but modulated other pathways differently after 6 months of supplementation, with sex-specific responses.

Original languageEnglish
Pages (from-to)e688
JournalClinics (Sao Paulo, Brazil)
Volume74
DOIs
Publication statusPublished - 7 Mar 2019

Fingerprint

Tocotrienols
Tocopherols
Vitamin E
Gene Expression
Cell Adhesion
Signal Transduction
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Malaysia
Xenobiotics
Microarray Analysis
Mitogen-Activated Protein Kinases
GTP-Binding Proteins
Mitosis
Synaptic Transmission
Pharmaceutical Preparations
Genes
Placebos
Apoptosis
Bacteria

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults. / Ghani, Siti Madiani Abdul; Jo Aan, Goon; Azman, Nor Helwa Ezzah Nor; Zakaria, Siti Nor Asyikin; Hamid, Zalina; Ngah, Wan Zurinah Wan.

In: Clinics (Sao Paulo, Brazil), Vol. 74, 07.03.2019, p. e688.

Research output: Contribution to journalArticle

Ghani, Siti Madiani Abdul ; Jo Aan, Goon ; Azman, Nor Helwa Ezzah Nor ; Zakaria, Siti Nor Asyikin ; Hamid, Zalina ; Ngah, Wan Zurinah Wan. / Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults. In: Clinics (Sao Paulo, Brazil). 2019 ; Vol. 74. pp. e688.
@article{02bf31260fb5414c896a772f36833231,
title = "Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults",
abstract = "OBJECTIVES: This study aims to compare the differential gene expression resulting from tocotrienol-rich fraction and α-tocopherol supplementation in healthy older adults. METHODS: A total of 71 eligible subjects aged 50 to 55 years from Gombak and Kuala Lumpur, Malaysia, were divided into three groups and supplemented with placebo (n=23), α-tocopherol (n=24) or tocotrienol-rich fraction (n=24). Blood samples were collected at baseline and at 3 and 6 months of supplementation for microarray analysis. RESULTS: The number of genes altered by α-tocopherol was higher after 6 months (1,410) than after 3 months (273) of supplementation. α-Tocopherol altered the expression of more genes in males (952) than in females (731). Similarly, tocotrienol-rich fraction modulated the expression of more genes after 6 months (1,084) than after 3 months (596) and affected more genes in males (899) than in females (781). α-Tocopherol supplementation modulated pathways involving the response to stress and stimuli, the immune response, the response to hypoxia and bacteria, the metabolism of toxins and xenobiotics, mitosis, and synaptic transmission as well as activated the mitogen-activated protein kinase and complement pathways after 6 months. However, tocotrienol-rich fraction supplementation affected pathways such as the signal transduction, apoptosis, nuclear factor kappa B kinase, cascade extracellular signal-regulated kinase-1 and extracellular signal-regulated kinase-2, immune response, response to drug, cell adhesion, multicellular organismal development and G protein signaling pathways. CONCLUSION: Supplementation with either α-tocopherol or tocotrienol-rich fraction affected the immune and drug response and the cell adhesion and signal transduction pathways but modulated other pathways differently after 6 months of supplementation, with sex-specific responses.",
author = "Ghani, {Siti Madiani Abdul} and {Jo Aan}, Goon and Azman, {Nor Helwa Ezzah Nor} and Zakaria, {Siti Nor Asyikin} and Zalina Hamid and Ngah, {Wan Zurinah Wan}",
year = "2019",
month = "3",
day = "7",
doi = "10.6061/clinics/2019/e688",
language = "English",
volume = "74",
pages = "e688",
journal = "Clinics",
issn = "1807-5932",
publisher = "University of Sao Paolo",

}

TY - JOUR

T1 - Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults

AU - Ghani, Siti Madiani Abdul

AU - Jo Aan, Goon

AU - Azman, Nor Helwa Ezzah Nor

AU - Zakaria, Siti Nor Asyikin

AU - Hamid, Zalina

AU - Ngah, Wan Zurinah Wan

PY - 2019/3/7

Y1 - 2019/3/7

N2 - OBJECTIVES: This study aims to compare the differential gene expression resulting from tocotrienol-rich fraction and α-tocopherol supplementation in healthy older adults. METHODS: A total of 71 eligible subjects aged 50 to 55 years from Gombak and Kuala Lumpur, Malaysia, were divided into three groups and supplemented with placebo (n=23), α-tocopherol (n=24) or tocotrienol-rich fraction (n=24). Blood samples were collected at baseline and at 3 and 6 months of supplementation for microarray analysis. RESULTS: The number of genes altered by α-tocopherol was higher after 6 months (1,410) than after 3 months (273) of supplementation. α-Tocopherol altered the expression of more genes in males (952) than in females (731). Similarly, tocotrienol-rich fraction modulated the expression of more genes after 6 months (1,084) than after 3 months (596) and affected more genes in males (899) than in females (781). α-Tocopherol supplementation modulated pathways involving the response to stress and stimuli, the immune response, the response to hypoxia and bacteria, the metabolism of toxins and xenobiotics, mitosis, and synaptic transmission as well as activated the mitogen-activated protein kinase and complement pathways after 6 months. However, tocotrienol-rich fraction supplementation affected pathways such as the signal transduction, apoptosis, nuclear factor kappa B kinase, cascade extracellular signal-regulated kinase-1 and extracellular signal-regulated kinase-2, immune response, response to drug, cell adhesion, multicellular organismal development and G protein signaling pathways. CONCLUSION: Supplementation with either α-tocopherol or tocotrienol-rich fraction affected the immune and drug response and the cell adhesion and signal transduction pathways but modulated other pathways differently after 6 months of supplementation, with sex-specific responses.

AB - OBJECTIVES: This study aims to compare the differential gene expression resulting from tocotrienol-rich fraction and α-tocopherol supplementation in healthy older adults. METHODS: A total of 71 eligible subjects aged 50 to 55 years from Gombak and Kuala Lumpur, Malaysia, were divided into three groups and supplemented with placebo (n=23), α-tocopherol (n=24) or tocotrienol-rich fraction (n=24). Blood samples were collected at baseline and at 3 and 6 months of supplementation for microarray analysis. RESULTS: The number of genes altered by α-tocopherol was higher after 6 months (1,410) than after 3 months (273) of supplementation. α-Tocopherol altered the expression of more genes in males (952) than in females (731). Similarly, tocotrienol-rich fraction modulated the expression of more genes after 6 months (1,084) than after 3 months (596) and affected more genes in males (899) than in females (781). α-Tocopherol supplementation modulated pathways involving the response to stress and stimuli, the immune response, the response to hypoxia and bacteria, the metabolism of toxins and xenobiotics, mitosis, and synaptic transmission as well as activated the mitogen-activated protein kinase and complement pathways after 6 months. However, tocotrienol-rich fraction supplementation affected pathways such as the signal transduction, apoptosis, nuclear factor kappa B kinase, cascade extracellular signal-regulated kinase-1 and extracellular signal-regulated kinase-2, immune response, response to drug, cell adhesion, multicellular organismal development and G protein signaling pathways. CONCLUSION: Supplementation with either α-tocopherol or tocotrienol-rich fraction affected the immune and drug response and the cell adhesion and signal transduction pathways but modulated other pathways differently after 6 months of supplementation, with sex-specific responses.

UR - http://www.scopus.com/inward/record.url?scp=85062817186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062817186&partnerID=8YFLogxK

U2 - 10.6061/clinics/2019/e688

DO - 10.6061/clinics/2019/e688

M3 - Article

C2 - 30864639

AN - SCOPUS:85062817186

VL - 74

SP - e688

JO - Clinics

JF - Clinics

SN - 1807-5932

ER -